- Home
- CLLS vs NNOX Comparison
CLLS vs NNOX Comparison
Compare CLLS & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- NNOX
- Stock Information
- Founded
- CLLS 1999
- NNOX 2011
- Country
- CLLS France
- NNOX Israel
- Employees
- CLLS N/A
- NNOX N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- NNOX Medical Electronics
- Sector
- CLLS Health Care
- NNOX Health Care
- Exchange
- CLLS Nasdaq
- NNOX Nasdaq
- Market Cap
- CLLS 299.0M
- NNOX 253.8M
- IPO Year
- CLLS 2007
- NNOX 2020
- Fundamental
- Price
- CLLS $3.49
- NNOX $4.06
- Analyst Decision
- CLLS Buy
- NNOX Strong Buy
- Analyst Count
- CLLS 1
- NNOX 2
- Target Price
- CLLS $8.00
- NNOX $8.50
- AVG Volume (30 Days)
- CLLS 212.5K
- NNOX 1.4M
- Earning Date
- CLLS 11-03-2025
- NNOX 11-20-2025
- Dividend Yield
- CLLS N/A
- NNOX N/A
- EPS Growth
- CLLS N/A
- NNOX N/A
- EPS
- CLLS N/A
- NNOX N/A
- Revenue
- CLLS $63,438,000.00
- NNOX $11,886,000.00
- Revenue This Year
- CLLS N/A
- NNOX $20.50
- Revenue Next Year
- CLLS $66.76
- NNOX $64.10
- P/E Ratio
- CLLS N/A
- NNOX N/A
- Revenue Growth
- CLLS 223.09
- NNOX 17.36
- 52 Week Low
- CLLS $1.10
- NNOX $3.60
- 52 Week High
- CLLS $5.48
- NNOX $11.00
- Technical
- Relative Strength Index (RSI)
- CLLS 47.81
- NNOX 50.18
- Support Level
- CLLS $3.39
- NNOX $3.86
- Resistance Level
- CLLS $5.48
- NNOX $4.32
- Average True Range (ATR)
- CLLS 0.38
- NNOX 0.25
- MACD
- CLLS -0.10
- NNOX 0.01
- Stochastic Oscillator
- CLLS 6.38
- NNOX 34.62
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.